Why the study?
Sleep apnea syndrome is common and linked to worse prognosis in HF, but remains an underestimated factor contributing to HF development and progression.
This review highlights the high prevalence and prognostic impact of sleep apnea syndrome in patients with heart failure, summarizing current knowledge on diagnosis, evaluation, and treatment.
Supports sleep apnea evaluation in heart failure; leaves open optimal treatment strategies pending prospective trials.
Heart failure (HF) affects many patients worldwide every year. It represents a leading cause of hospitalization and still, today, mortality remains high, albeit the progress in treatment strategies. Several factors contribute to the development and progression of HF. Among these, sleep apnea syndrome represents a common but still underestimated factor because its prevalence is substantially higher in patients with HF than in the general population and is related to a worse prognosis. This review summarizes the current knowledge about sleep apnea syndrome coexisting with HF in terms of morbidity and mortality to provide actual and future perspectives about the diagnosis, evaluation, and treatment of this association.
No takes yet. Share an insight, caveat, or question.
Piccirillo et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: